Global Liver Failure Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jan-2021
No. of pages: 99
Inquire Before Buying

Liver Failure Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Failure Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Ornithine Phenylacetate

- MTL-CEBPA

- F-573

- BL-1220

- PP-100

- Others

Segment by Application

- Clinic

- Hospital

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Alfact Innovation

- BioLineRx Ltd

- Cell2B Advanced Therapeutics SA

- Conatus Pharmaceuticals Inc

- Immune Pharmaceuticals Inc

- Mina Therapeutics Ltd

- Mylan NV

- Ocera Therapeutics Inc

- PledPharma AB

- Conatus Pharmaceuticals Inc

- Immune Pharmaceuticals Inc

- Unicyte AG

- Ventria Bioscience

Global Liver Failure Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Failure Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ornithine Phenylacetate
1.2.3 MTL-CEBPA
1.2.4 F-573
1.2.5 BL-1220
1.2.6 PP-100
1.2.7 Others
1.3 Market by Application
1.3.1 Global Liver Failure Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Liver Failure Therapeutics Market Perspective (2016-2027)
2.2 Liver Failure Therapeutics Growth Trends by Regions
2.2.1 Liver Failure Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Liver Failure Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Liver Failure Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Liver Failure Therapeutics Industry Dynamic
2.3.1 Liver Failure Therapeutics Market Trends
2.3.2 Liver Failure Therapeutics Market Drivers
2.3.3 Liver Failure Therapeutics Market Challenges
2.3.4 Liver Failure Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Failure Therapeutics Players by Revenue
3.1.1 Global Top Liver Failure Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Liver Failure Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Liver Failure Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Liver Failure Therapeutics Revenue
3.4 Global Liver Failure Therapeutics Market Concentration Ratio
3.4.1 Global Liver Failure Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Failure Therapeutics Revenue in 2020
3.5 Liver Failure Therapeutics Key Players Head office and Area Served
3.6 Key Players Liver Failure Therapeutics Product Solution and Service
3.7 Date of Enter into Liver Failure Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Failure Therapeutics Breakdown Data by Type
4.1 Global Liver Failure Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Liver Failure Therapeutics Forecasted Market Size by Type (2022-2027)
5 Liver Failure Therapeutics Breakdown Data by Application
5.1 Global Liver Failure Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Liver Failure Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Liver Failure Therapeutics Market Size (2016-2027)
6.2 North America Liver Failure Therapeutics Market Size by Type
6.2.1 North America Liver Failure Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Liver Failure Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Liver Failure Therapeutics Market Size by Type (2016-2027)
6.3 North America Liver Failure Therapeutics Market Size by Application
6.3.1 North America Liver Failure Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Liver Failure Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Liver Failure Therapeutics Market Size by Application (2016-2027)
6.4 North America Liver Failure Therapeutics Market Size by Country
6.4.1 North America Liver Failure Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Liver Failure Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Liver Failure Therapeutics Market Size (2016-2027)
7.2 Europe Liver Failure Therapeutics Market Size by Type
7.2.1 Europe Liver Failure Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Liver Failure Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Liver Failure Therapeutics Market Size by Type (2016-2027)
7.3 Europe Liver Failure Therapeutics Market Size by Application
7.3.1 Europe Liver Failure Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Liver Failure Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Liver Failure Therapeutics Market Size by Application (2016-2027)
7.4 Europe Liver Failure Therapeutics Market Size by Country
7.4.1 Europe Liver Failure Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Liver Failure Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Liver Failure Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Liver Failure Therapeutics Market Size by Type
8.2.1 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Liver Failure Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Liver Failure Therapeutics Market Size by Application
8.3.1 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Liver Failure Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Liver Failure Therapeutics Market Size by Region
8.4.1 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Liver Failure Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Liver Failure Therapeutics Market Size (2016-2027)
9.2 Latin America Liver Failure Therapeutics Market Size by Type
9.2.1 Latin America Liver Failure Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Liver Failure Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Liver Failure Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Liver Failure Therapeutics Market Size by Application
9.3.1 Latin America Liver Failure Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Liver Failure Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Liver Failure Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Liver Failure Therapeutics Market Size by Country
9.4.1 Latin America Liver Failure Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Liver Failure Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Failure Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type
10.2.1 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Liver Failure Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Liver Failure Therapeutics Market Size by Application
10.3.1 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Liver Failure Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Liver Failure Therapeutics Market Size by Country
10.4.1 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Liver Failure Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Alfact Innovation
11.1.1 Alfact Innovation Company Details
11.1.2 Alfact Innovation Business Overview
11.1.3 Alfact Innovation Liver Failure Therapeutics Introduction
11.1.4 Alfact Innovation Revenue in Liver Failure Therapeutics Business (2016-2021)
11.1.5 Alfact Innovation Recent Development
11.2 BioLineRx Ltd
11.2.1 BioLineRx Ltd Company Details
11.2.2 BioLineRx Ltd Business Overview
11.2.3 BioLineRx Ltd Liver Failure Therapeutics Introduction
11.2.4 BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2016-2021)
11.2.5 BioLineRx Ltd Recent Development
11.3 Cell2B Advanced Therapeutics SA
11.3.1 Cell2B Advanced Therapeutics SA Company Details
11.3.2 Cell2B Advanced Therapeutics SA Business Overview
11.3.3 Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Introduction
11.3.4 Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2016-2021)
11.3.5 Cell2B Advanced Therapeutics SA Recent Development
11.4 Conatus Pharmaceuticals Inc
11.4.1 Conatus Pharmaceuticals Inc Company Details
11.4.2 Conatus Pharmaceuticals Inc Business Overview
11.4.3 Conatus Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.4.4 Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.4.5 Conatus Pharmaceuticals Inc Recent Development
11.5 Immune Pharmaceuticals Inc
11.5.1 Immune Pharmaceuticals Inc Company Details
11.5.2 Immune Pharmaceuticals Inc Business Overview
11.5.3 Immune Pharmaceuticals Inc Liver Failure Therapeutics Introduction
11.5.4 Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.5.5 Immune Pharmaceuticals Inc Recent Development
11.6 Mina Therapeutics Ltd
11.6.1 Mina Therapeutics Ltd Company Details
11.6.2 Mina Therapeutics Ltd Business Overview
11.6.3 Mina Therapeutics Ltd Liver Failure Therapeutics Introduction
11.6.4 Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2016-2021)
11.6.5 Mina Therapeutics Ltd Recent Development
11.7 Mylan NV
11.7.1 Mylan NV Company Details
11.7.2 Mylan NV Business Overview
11.7.3 Mylan NV Liver Failure Therapeutics Introduction
11.7.4 Mylan NV Revenue in Liver Failure Therapeutics Business (2016-2021)
11.7.5 Mylan NV Recent Development
11.8 Ocera Therapeutics Inc
11.8.1 Ocera Therapeutics Inc Company Details
11.8.2 Ocera Therapeutics Inc Business Overview
11.8.3 Ocera Therapeutics Inc Liver Failure Therapeutics Introduction
11.8.4 Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.8.5 Ocera Therapeutics Inc Recent Development
11.9 PledPharma AB
11.9.1 PledPharma AB Company Details
11.9.2 PledPharma AB Business Overview
11.9.3 PledPharma AB Liver Failure Therapeutics Introduction
11.9.4 PledPharma AB Revenue in Liver Failure Therapeutics Business (2016-2021)
11.9.5 PledPharma AB Recent Development
11.10 Promethera Biosciences SA
11.10.1 Promethera Biosciences SA Company Details
11.10.2 Promethera Biosciences SA Business Overview
11.10.3 Promethera Biosciences SA Liver Failure Therapeutics Introduction
11.10.4 Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2016-2021)
11.10.5 Promethera Biosciences SA Recent Development
11.11 Silence Therapeutics Plc
11.11.1 Silence Therapeutics Plc Company Details
11.11.2 Silence Therapeutics Plc Business Overview
11.11.3 Silence Therapeutics Plc Liver Failure Therapeutics Introduction
11.11.4 Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.11.5 Silence Therapeutics Plc Recent Development
11.12 Unicyte AG
11.12.1 Unicyte AG Company Details
11.12.2 Unicyte AG Business Overview
11.12.3 Unicyte AG Liver Failure Therapeutics Introduction
11.12.4 Unicyte AG Revenue in Liver Failure Therapeutics Business (2016-2021)
11.12.5 Unicyte AG Recent Development
11.13 Ventria Bioscience
11.13.1 Ventria Bioscience Company Details
11.13.2 Ventria Bioscience Business Overview
11.13.3 Ventria Bioscience Liver Failure Therapeutics Introduction
11.13.4 Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2016-2021)
11.13.5 Ventria Bioscience Recent Development
11.14 Vital Therapies Inc
11.14.1 Vital Therapies Inc Company Details
11.14.2 Vital Therapies Inc Business Overview
11.14.3 Vital Therapies Inc Liver Failure Therapeutics Introduction
11.14.4 Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2016-2021)
11.14.5 Vital Therapies Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Liver Failure Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ornithine Phenylacetate
Table 3. Key Players of MTL-CEBPA
Table 4. Key Players of F-573
Table 5. Key Players of BL-1220
Table 6. Key Players of PP-100
Table 7. Key Players of Others
Table 8. Global Liver Failure Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Liver Failure Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Liver Failure Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Liver Failure Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Liver Failure Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Liver Failure Therapeutics Market Share by Regions (2022-2027)
Table 14. Liver Failure Therapeutics Market Trends
Table 15. Liver Failure Therapeutics Market Drivers
Table 16. Liver Failure Therapeutics Market Challenges
Table 17. Liver Failure Therapeutics Market Restraints
Table 18. Global Liver Failure Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Liver Failure Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2020)
Table 21. Ranking of Global Top Liver Failure Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Liver Failure Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Liver Failure Therapeutics Product Solution and Service
Table 25. Date of Enter into Liver Failure Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Liver Failure Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Liver Failure Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Liver Failure Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Liver Failure Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Liver Failure Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Liver Failure Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Liver Failure Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Liver Failure Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Liver Failure Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Liver Failure Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Liver Failure Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Liver Failure Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Liver Failure Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Liver Failure Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Liver Failure Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Alfact Innovation Company Details
Table 66. Alfact Innovation Business Overview
Table 67. Alfact Innovation Liver Failure Therapeutics Product
Table 68. Alfact Innovation Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Alfact Innovation Recent Development
Table 70. BioLineRx Ltd Company Details
Table 71. BioLineRx Ltd Business Overview
Table 72. BioLineRx Ltd Liver Failure Therapeutics Product
Table 73. BioLineRx Ltd Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 74. BioLineRx Ltd Recent Development
Table 75. Cell2B Advanced Therapeutics SA Company Details
Table 76. Cell2B Advanced Therapeutics SA Business Overview
Table 77. Cell2B Advanced Therapeutics SA Liver Failure Therapeutics Product
Table 78. Cell2B Advanced Therapeutics SA Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Cell2B Advanced Therapeutics SA Recent Development
Table 80. Conatus Pharmaceuticals Inc Company Details
Table 81. Conatus Pharmaceuticals Inc Business Overview
Table 82. Conatus Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 83. Conatus Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 84. Conatus Pharmaceuticals Inc Recent Development
Table 85. Immune Pharmaceuticals Inc Company Details
Table 86. Immune Pharmaceuticals Inc Business Overview
Table 87. Immune Pharmaceuticals Inc Liver Failure Therapeutics Product
Table 88. Immune Pharmaceuticals Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 89. Immune Pharmaceuticals Inc Recent Development
Table 90. Mina Therapeutics Ltd Company Details
Table 91. Mina Therapeutics Ltd Business Overview
Table 92. Mina Therapeutics Ltd Liver Failure Therapeutics Product
Table 93. Mina Therapeutics Ltd Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Mina Therapeutics Ltd Recent Development
Table 95. Mylan NV Company Details
Table 96. Mylan NV Business Overview
Table 97. Mylan NV Liver Failure Therapeutics Product
Table 98. Mylan NV Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Mylan NV Recent Development
Table 100. Ocera Therapeutics Inc Company Details
Table 101. Ocera Therapeutics Inc Business Overview
Table 102. Ocera Therapeutics Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 103. Ocera Therapeutics Inc Recent Development
Table 104. PledPharma AB Company Details
Table 105. PledPharma AB Business Overview
Table 106. PledPharma AB Liver Failure Therapeutics Product
Table 107. PledPharma AB Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 108. PledPharma AB Recent Development
Table 109. Promethera Biosciences SA Company Details
Table 110. Promethera Biosciences SA Business Overview
Table 111. Promethera Biosciences SA Liver Failure Therapeutics Product
Table 112. Promethera Biosciences SA Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 113. Promethera Biosciences SA Recent Development
Table 114. Silence Therapeutics Plc Company Details
Table 115. Silence Therapeutics Plc Business Overview
Table 116. Silence Therapeutics Plc Liver Failure Therapeutics Product
Table 117. Silence Therapeutics Plc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 118. Silence Therapeutics Plc Recent Development
Table 119. Unicyte AG Company Details
Table 120. Unicyte AG Business Overview
Table 121. Unicyte AG Liver Failure Therapeutics Product
Table 122. Unicyte AG Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 123. Unicyte AG Recent Development
Table 124. Ventria Bioscience Company Details
Table 125. Ventria Bioscience Business Overview
Table 126. Ventria Bioscience Liver Failure Therapeutics Product
Table 127. Ventria Bioscience Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 128. Ventria Bioscience Recent Development
Table 129. Vital Therapies Inc Company Details
Table 130. Vital Therapies Inc Business Overview
Table 131. Vital Therapies Inc Liver Failure Therapeutics Product
Table 132. Vital Therapies Inc Revenue in Liver Failure Therapeutics Business (2016-2021) & (US$ Million)
Table 133. Vital Therapies Inc Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Failure Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Ornithine Phenylacetate Features
Figure 3. MTL-CEBPA Features
Figure 4. F-573 Features
Figure 5. BL-1220 Features
Figure 6. PP-100 Features
Figure 7. Others Features
Figure 8. Global Liver Failure Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Liver Failure Therapeutics Report Years Considered
Figure 13. Global Liver Failure Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Liver Failure Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Liver Failure Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Liver Failure Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Liver Failure Therapeutics Market Share by Players in 2020
Figure 18. Global Top Liver Failure Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Failure Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Liver Failure Therapeutics Revenue in 2020
Figure 20. Global Liver Failure Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Liver Failure Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Liver Failure Therapeutics Market Share by Region (2016-2027)
Figure 42. China Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Liver Failure Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Liver Failure Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Liver Failure Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Liver Failure Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Alfact Innovation Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 62. BioLineRx Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 63. Cell2B Advanced Therapeutics SA Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 64. Conatus Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 65. Immune Pharmaceuticals Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 66. Mina Therapeutics Ltd Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 67. Mylan NV Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 68. Ocera Therapeutics Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 69. PledPharma AB Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 70. Promethera Biosciences SA Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 71. Silence Therapeutics Plc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 72. Unicyte AG Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 73. Ventria Bioscience Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 74. Vital Therapies Inc Revenue Growth Rate in Liver Failure Therapeutics Business (2016-2021)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Lumbar Artificial Disc Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Metal - Biopolymer Segment by Application - Hospitals - Ambulatory Surgical Centers......
  • Global Artificial Discs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Cervical Artificial Disc - Lumbar Artificial Disc Segment by Application - Hospitals ......
  • Global Choroidal Neovascularization Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 91
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Intravenous - Intravitreal Segment by Application - Extreme Myopia - Malignant Myopic......
  • Global Cerebrospinal Fluid (CSF) Management Devices Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - CSF Shunts - CSF Drainage Systems Segment by Application - Hospitals - Ambulatory Sur......
  • Global Cerebral and Tissue Oximetry Devices Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 122
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Portable - Desktop Segment by Application - Clinical - Hospitals - Others......
  • Global Axial Bone Densitometer Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - DEXA Axial Bone Densitometer - QCT Axial Bone Densitometer Segment by Application - Hospital......
  • Global CPAP Humidifier Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 115
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tem-Control - Others Segment by Application - Hospital - Residential - Others......
  • Global Transfer Bench Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 95
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Retractable - Ordinary Segment by Application - Residential - Commercial - Oth......
  • Global CPAP Humidifiers Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 119
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tem-Control - Others Segment by Application - Hospital - Residential - Others......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs